Publication | Open Access
Development of an <i>in vivo</i> target‐engagement biomarker for TRPA1 antagonists in humans
14
Citations
30
References
2016
Year
Evaluation of CA-induced changes in DBF offers a safe, non-invasive and reproducible target-engagement biomarker in vivo in humans to evaluate TRPA1 antagonists.
| Year | Citations | |
|---|---|---|
Page 1
Page 1